Abivax SA announced the appointment of Ana Sharma as Vice President, Global Head of Quality. Ms. Sharma brings over 20 years of experience in the biopharmaceutical industry and has a strong track record in quality and GxP compliance. She has helped bring over 30 drugs to market across multiple therapeutic areas, including gastroenterology and immunology.

She has experience managing large international teams and regulatory authority interactions and inspections worldwide. Ana Sharma joined Abivax from Takeda, where she held the position of Vice President, Global Head of Research and Development Clinical Quality Assurance. Previously, she worked for Novartis, Amgen and Dana-Farber/Harvard Cancer Center where she occupied different quality positions with increasing levels of responsibility.

Ms. Sharma is focused on patient safety, patient rights and patient well-being, as well as data integrity, product quality, data privacy and regulatory compliance. She holds a Master of Public Health, Epidemiology and Biostatistics from Boston University, MA, US.